Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
Estudio aleatorizado, doble ciego, de dos brazos, controlado con placebo y de 12 meses de duración de los efectos de rimonabant 20 mg una vez al día sobre la cantidad y actividad de la grasa visceral en pacientes con obesidad abdominal y síndrome metabólico. A randomized, double blind, two-arm placebo controlled, 12-Month study of the effects of rimonabant 20 mg once daily on the amount and the activity of visceral fat in abdominally obese patients with metabolic syndrome https://kusajili.fr:443/Trial/V3TgZS7eh0u4HBic8moyrA%24estudio-aleatorizado-doble-ciego-de-dos-brazos-controlado-con-placebo-y-de-12-meses-de-duracion-de-los-efectos-de-rimonabant-20
I have read and accept the terms of use of the site and the Privacy Policy
Send your message